The PE Ratio as of November 2024 (TTM) for Oramed Pharmaceuticals Inc. (ORMP) is 21.27

According to Oramed Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 21.27. This represents a change of -232.50% compared to the average of -16.05 of the last 4 quarters.

Oramed Pharmaceuticals Inc. (ORMP) Historical PE Ratio (quarterly & annually)

How has ORMP PE Ratio performed in the past?

The mean historical PE Ratio of Oramed Pharmaceuticals Inc. over the last ten years is -11.02. The current 21.27 PE Ratio has changed -19394.47% with respect to the historical average. Over the past ten years (40 quarters), ORMP's PE Ratio was at its highest in in the May 2019 quarter at -3.22. The PE Ratio was at its lowest in in the February 2014 quarter at -30.42.

Oramed Pharmaceuticals Inc. (ORMP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Oramed Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oramed Pharmaceuticals Inc. (ORMP) Average PE Ratio

How has ORMP PE Ratio performed in the past?

The current PE Ratio of Oramed Pharmaceuticals Inc. (ORMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oramed Pharmaceuticals Inc. (ORMP) PE Ratio vs. Peers

How is ORMP’s PE Ratio compared to its peers?

Oramed Pharmaceuticals Inc.’s PE Ratio is greater than Protalix BioTherapeutics, Inc. (-12.94), greater than Corvus Pharmaceuticals, Inc. (-10.50), greater than Aldeyra Therapeutics, Inc. (-6.45), greater than Gamida Cell Ltd. (-0.23), greater than Checkpoint Therapeutics, Inc. (-3.48), greater than BioLineRx Ltd. (-0.74), greater than Ardelyx, Inc. (-17.26), greater than Lexicon Pharmaceuticals, Inc. (-1.45), greater than Seres Therapeutics, Inc. (-4.61), greater than ImmunityBio, Inc. (-6.04), greater than X4 Pharmaceuticals, Inc. (-4.05), greater than Mereo BioPharma Group plc (-13.56), greater than Inozyme Pharma, Inc. (-1.84), greater than Terns Pharmaceuticals, Inc. (-5.12), greater than Leap Therapeutics, Inc. (-1.63), greater than Zura Bio Limited (-5.60), greater than Altamira Therapeutics Ltd. (-0.03), greater than Immix Biopharma, Inc. (-2.41), greater than Enveric Biosciences, Inc. (-0.29), greater than Palisade Bio, Inc. (-0.26), greater than Hepion Pharmaceuticals, Inc. (-0.20), greater than AVROBIO, Inc. (2.07), greater than CohBar, Inc. (-0.12), greater than Ocean Biomedical, Inc. (-0.71), greater than Elevation Oncology, Inc. (-0.85),

Build a custom stock screener for Oramed Pharmaceuticals Inc. (ORMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oramed Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oramed Pharmaceuticals Inc. (ORMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oramed Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.